Will Procreation Ever Be The Same After COVID-19?

Area of Science:

• Reproductive Endocrinology
• Infectious Diseases
• Virology

Background:

• The COVID-19 pandemic has significantly impacted medically assisted procreation (MAP) services globally.
• Emerging concerns include SARS-CoV-2 infection's effects on natural and assisted reproduction, and potential long-term reproductive consequences.
• Hypotheses suggest COVID-19 may cause testicular damage and infertility, with SARS-CoV-2 detected in semen, raising questions about sexual transmission.

Discussion:

• Vaccine hesitancy is fueled by misinformation regarding COVID-19 vaccines and female sterility.
• Clinical trial data from accidental pregnancies show no adverse effects of COVID-19 vaccination on fertility or miscarriage rates.
• Good tissue practices in in vitro fertilization (IVF) are being re-evaluated, considering ova, sperm, and embryos as potential SARS-CoV-2 vectors.

Key Insights:

• Current strategies for IVF involve segmented procedures, embryo cryopreservation, and delayed embryo transfer to mitigate pandemic-related risks.
• Research is ongoing to understand the full scope of reproductive implications associated with SARS-CoV-2 infection.
• International researchers propose prognostic stratification for vulnerable infertility cases to guide the safe resumption of fertility treatments.

Outlook:

• Further research is crucial to fully understand the reproductive health implications of COVID-19 and its long-term effects.
• Developing robust protocols for MAP services during and after the pandemic is essential.
• Continued monitoring and data collection on vaccine safety in reproductive contexts are necessary.